Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Onychomycosis (Tinea Unguium) Drug Market 2018 Forecast to 2023

May 2018 | 100 pages | ID: G670FED5CC9EN
GlobalInfoResearch

Abstracts

'Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate.
Onychomycosis (Tinea Unguium) Drug is the drug for the treatment of the disease'

Scope of the Report:

This report focuses on the Onychomycosis (Tinea Unguium) Drug in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.


Market Segment by Manufacturers, this report covers

• Johnson & Johnson
• GSK
• Novartis
• Pfizer
• Valeant Pharma
• Kaken Pharmaceutical
• Galderma
• Xiuzheng Pharmaceutical
• Letai
• Qilu Pharmaceutical

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Oral
• External

Market Segment by Applications, can be divided into

• Age under 18
• Age 18-50
• Age above 50

There are 15 Chapters to deeply display the global Onychomycosis (Tinea Unguium) Drug market.

Chapter 1, to describe Onychomycosis (Tinea Unguium) Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Onychomycosis (Tinea Unguium) Drug , with sales, revenue, and price of Onychomycosis (Tinea Unguium) Drug , in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Onychomycosis (Tinea Unguium) Drug , for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Onychomycosis (Tinea Unguium) Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Onychomycosis (Tinea Unguium) Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Onychomycosis (Tinea Unguium) Drug Introduction
1.2 Market Analysis by Type
  1.2.1 Oral
  1.2.2 External
1.3 Market Analysis by Applications
  1.3.1 Age under
  1.3.2 Age 18-50
  1.3.3 Age above
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Johnson & Johnson
  2.1.1 Business Overview
  2.1.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 GSK
  2.2.1 Business Overview
  2.2.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 GSK Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis
  2.3.1 Business Overview
  2.3.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 Novartis Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
  2.4.1 Business Overview
  2.4.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 Pfizer Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Valeant Pharma
  2.5.1 Business Overview
  2.5.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Kaken Pharmaceutical
  2.6.1 Business Overview
  2.6.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Galderma
  2.7.1 Business Overview
  2.7.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    2.7.2.1 Type
    2.7.2.2 Type
  2.7.3 Galderma Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Xiuzheng Pharmaceutical
  2.8.1 Business Overview
  2.8.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    2.8.2.1 Type
    2.8.2.2 Type
  2.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Letai
  2.9.1 Business Overview
  2.9.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    2.9.2.1 Type
    2.9.2.2 Type
  2.9.3 Letai Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Qilu Pharmaceutical
  2.10.1 Business Overview
  2.10.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
    2.10.2.1 Type
    2.10.2.2 Type
  2.10.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET COMPETITION, BY MANUFACTURER

3.1 Global Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Onychomycosis (Tinea Unguium) Drug Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Onychomycosis (Tinea Unguium) Drug Manufacturer Market Share in 2017
  3.4.2 Top 5 Onychomycosis (Tinea Unguium) Drug Manufacturer Market Share in 2017
3.5 Market Competition Trend

4 GLOBAL ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET ANALYSIS BY REGIONS

4.1 Global Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Regions
  4.1.1 Global Onychomycosis (Tinea Unguium) Drug Sales by Regions (2013-2018)
  4.1.2 Global Onychomycosis (Tinea Unguium) Drug Revenue by Regions (2013-2018)
4.2 North America Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 North America Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Countries
  5.1.1 North America Onychomycosis (Tinea Unguium) Drug Sales by Countries (2013-2018)
  5.1.2 North America Onychomycosis (Tinea Unguium) Drug Revenue by Countries (2013-2018)
  5.1.3 United States Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
  5.1.4 Canada Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
  5.1.5 Mexico Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
5.2 North America Onychomycosis (Tinea Unguium) Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
  5.2.1 North America Onychomycosis (Tinea Unguium) Drug Sales by Manufacturers (2016-2017)
  5.2.2 North America Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturers (2016-2017)
5.3 North America Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Type (2013-2018)
  5.3.1 North America Onychomycosis (Tinea Unguium) Drug Sales and Sales Share by Type (2013-2018)
  5.3.2 North America Onychomycosis (Tinea Unguium) Drug Revenue and Revenue Share by Type (2013-2018)
5.4 North America Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Application (2013-2018)
  5.4.1 North America Onychomycosis (Tinea Unguium) Drug Sales and Sales Share by Application (2013-2018)
  5.4.2 North America Onychomycosis (Tinea Unguium) Drug Revenue and Revenue Share by Application (2013-2018)

6 EUROPE ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Europe Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Countries
  6.1.1 Europe Onychomycosis (Tinea Unguium) Drug Sales by Countries (2013-2018)
  6.1.2 Europe Onychomycosis (Tinea Unguium) Drug Revenue by Countries (2013-2018)
  6.1.3 Germany Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
  6.1.4 UK Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
  6.1.5 France Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
  6.1.6 Russia Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
  6.1.7 Italy Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
6.2 Europe Onychomycosis (Tinea Unguium) Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
  6.2.1 Europe Onychomycosis (Tinea Unguium) Drug Sales by Manufacturers (2016-2017)
  6.2.2 Europe Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturers (2016-2017)
6.3 Europe Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Type (2013-2018)
  6.3.1 Europe Onychomycosis (Tinea Unguium) Drug Sales and Sales Share by Type (2013-2018)
  6.3.2 Europe Onychomycosis (Tinea Unguium) Drug Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Application (2013-2018)
  6.4.1 Europe Onychomycosis (Tinea Unguium) Drug Sales and Sales Share by Application (2013-2018)
  6.4.2 Europe Onychomycosis (Tinea Unguium) Drug Revenue and Revenue Share by Application (2013-2018)

7 ASIA-PACIFIC ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales by Countries (2013-2018)
  7.1.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Countries (2013-2018)
  7.1.3 China Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
  7.1.4 Japan Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
  7.1.5 Korea Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
  7.1.6 India Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
  7.1.7 Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
  7.2.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales by Manufacturers (2016-2017)
  7.2.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Type (2013-2018)
  7.3.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales and Sales Share by Type (2013-2018)
  7.3.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Application (2013-2018)
  7.4.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales and Sales Share by Application (2013-2018)
  7.4.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue and Revenue Share by Application (2013-2018)

8 SOUTH AMERICA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

8.1 South America Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Countries
  8.1.1 South America Onychomycosis (Tinea Unguium) Drug Sales by Countries (2013-2018)
  8.1.2 South America Onychomycosis (Tinea Unguium) Drug Revenue by Countries (2013-2018)
  8.1.3 Brazil Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
  8.1.4 Argentina Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
  8.1.5 Colombia Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
8.2 South America Onychomycosis (Tinea Unguium) Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
  8.2.1 South America Onychomycosis (Tinea Unguium) Drug Sales by Manufacturers (2016-2017)
  8.2.2 South America Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturers (2016-2017)
8.3 South America Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Type (2013-2018)
  8.3.1 South America Onychomycosis (Tinea Unguium) Drug Sales and Sales Share by Type (2013-2018)
  8.3.2 South America Onychomycosis (Tinea Unguium) Drug Revenue and Revenue Share by Type (2013-2018)
8.4 South America Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Application (2013-2018)
  8.4.1 South America Onychomycosis (Tinea Unguium) Drug Sales and Sales Share by Application (2013-2018)
  8.4.2 South America Onychomycosis (Tinea Unguium) Drug Revenue and Revenue Share by Application (2013-2018)

9 MIDDLE EAST AND AFRICA ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

9.1 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales by Countries (2013-2018)
  9.1.2 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue by Countries (2013-2018)
  9.1.3 Saudi Arabia Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
  9.1.4 UAE Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
  9.1.5 Egypt Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
  9.1.6 Nigeria Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
  9.1.7 South Africa Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
  9.2.1 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales by Manufacturers (2016-2017)
  9.2.2 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Type (2013-2018)
  9.3.1 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales and Sales Share by Type (2013-2018)
  9.3.1 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Application (2013-2018)
  9.4.1 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales and Sales Share by Application (2013-2018)
  9.4.2 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue and Revenue Share by Application (2013-2018)

10 GLOBAL ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET SEGMENT BY TYPE

10.1 Global Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Type (2013-2018)
  10.1.2 Global Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Type (2013-2018)
10.2 Oral Sales Growth and Price
  10.2.1 Global Oral Sales Growth (2013-2018)
  10.2.2 Global Oral Price (2013-2018)
10.3 External Sales Growth and Price
  10.3.1 Global External Sales Growth (2013-2018)
  10.3.2 Global External Price (2013-2018)

11 GLOBAL ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET SEGMENT BY APPLICATION

11.1 Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2013-2018)
11.2 Age under 18 Sales Growth (2013-2018)
11.3 Age 18-50 Sales Growth (2013-2018)
11.4 Age above 50 Sales Growth (2013-2018)

12 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET FORECAST (2018-2023)

12.1 Global Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Onychomycosis (Tinea Unguium) Drug Market Forecast by Regions (2018-2023)
  12.2.1 North America Onychomycosis (Tinea Unguium) Drug Market Forecast (2018-2023)
  12.2.2 Europe Onychomycosis (Tinea Unguium) Drug Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Forecast (2018-2023)
  12.2.4 South America Onychomycosis (Tinea Unguium) Drug Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Forecast (2018-2023)
12.3 Onychomycosis (Tinea Unguium) Drug Market Forecast by Type (2018-2023)
  12.3.1 Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Type (2018-2023)
  12.3.2 Global Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Type (2018-2023)
12.4 Onychomycosis (Tinea Unguium) Drug Market Forecast by Application (2018-2023)
  12.4.1 Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Application (2018-2023)
  12.4.2 Global Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Onychomycosis (Tinea Unguium) Drug Picture
Table Product Specifications of Onychomycosis (Tinea Unguium) Drug
Figure Global Onychomycosis (Tinea Unguium) Drug CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Onychomycosis (Tinea Unguium) Drug CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Onychomycosis (Tinea Unguium) Drug by Types in 2017
Figure Oral Picture
Figure External Picture
Figure Onychomycosis (Tinea Unguium) Drug Sales Market Share by Applications in 2017
Figure Age under 18 Picture
Figure Age 18-50 Picture
Figure Age above 50 Picture
Figure United States Onychomycosis (Tinea Unguium) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Onychomycosis (Tinea Unguium) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Onychomycosis (Tinea Unguium) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Onychomycosis (Tinea Unguium) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure France Onychomycosis (Tinea Unguium) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure UK Onychomycosis (Tinea Unguium) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Onychomycosis (Tinea Unguium) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Onychomycosis (Tinea Unguium) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure China Onychomycosis (Tinea Unguium) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Onychomycosis (Tinea Unguium) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Onychomycosis (Tinea Unguium) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure India Onychomycosis (Tinea Unguium) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Onychomycosis (Tinea Unguium) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Onychomycosis (Tinea Unguium) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Onychomycosis (Tinea Unguium) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Onychomycosis (Tinea Unguium) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Onychomycosis (Tinea Unguium) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Onychomycosis (Tinea Unguium) Drug Revenue (Value) and Growth Rate (2013-2023)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Type and Applications
Table Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Onychomycosis (Tinea Unguium) Drug Type and Applications
Table GSK Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Onychomycosis (Tinea Unguium) Drug Type and Applications
Table Novartis Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Onychomycosis (Tinea Unguium) Drug Type and Applications
Table Pfizer Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Valeant Pharma Basic Information, Manufacturing Base and Competitors
Table Valeant Pharma Onychomycosis (Tinea Unguium) Drug Type and Applications
Table Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Kaken Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Type and Applications
Table Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Galderma Basic Information, Manufacturing Base and Competitors
Table Galderma Onychomycosis (Tinea Unguium) Drug Type and Applications
Table Galderma Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Xiuzheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Type and Applications
Table Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Letai Basic Information, Manufacturing Base and Competitors
Table Letai Onychomycosis (Tinea Unguium) Drug Type and Applications
Table Letai Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Type and Applications
Table Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Onychomycosis (Tinea Unguium) Drug Sales by Manufacturer (2016-2017)
Figure Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2016
Figure Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2017
Table Global Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturer (2016-2017)
Figure Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2016
Figure Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2017
Table Global Onychomycosis (Tinea Unguium) Drug Price by Manufacturer (2016-2017)
Figure Top 3 Onychomycosis (Tinea Unguium) Drug Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Onychomycosis (Tinea Unguium) Drug Manufacturer (Revenue) Market Share in 2017
Figure Global Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
Figure Global Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Table Global Onychomycosis (Tinea Unguium) Drug Sales by Regions (2013-2018)
Table Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Regions (2013-2018)
Table Global Onychomycosis (Tinea Unguium) Drug Revenue by Regions (2013-2018)
Figure Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Regions in 2013
Figure Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Regions in 2017
Figure North America Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
Figure North America Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Figure Europe Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
Figure Europe Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Figure South America Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
Figure South America Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Figure North America Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Table North America Onychomycosis (Tinea Unguium) Drug Sales by Countries (2013-2018)
Table North America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Countries (2013-2018)
Figure North America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Countries in 2013
Figure North America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Countries in 2017
Table North America Onychomycosis (Tinea Unguium) Drug Revenue by Countries (2013-2018)
Table North America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries (2013-2018)
Figure North America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries in 2013
Figure North America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries in 2017
Figure United States Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
Figure Canada Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
Figure Mexico Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
Table North America Onychomycosis (Tinea Unguium) Drug Sales by Manufacturer (2016-2017)
Figure North America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2016
Figure North America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2017
Table North America Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturer (2016-2017)
Figure North America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2016
Figure North America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2017
Table North America Onychomycosis (Tinea Unguium) Drug Sales by Type (2013-2018)
Table North America Onychomycosis (Tinea Unguium) Drug Sales Share by Type (2013-2018)
Table North America Onychomycosis (Tinea Unguium) Drug Revenue by Type (2013-2018)
Table North America Onychomycosis (Tinea Unguium) Drug Revenue Share by Type (2013-2018)
Table North America Onychomycosis (Tinea Unguium) Drug Sales by Application (2013-2018)
Table North America Onychomycosis (Tinea Unguium) Drug Sales Share by Application (2013-2018)
Table North America Onychomycosis (Tinea Unguium) Drug Revenue by Application (2013-2018)
Table North America Onychomycosis (Tinea Unguium) Drug Revenue Share by Application (2013-2018)
Figure Europe Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Table Europe Onychomycosis (Tinea Unguium) Drug Sales by Countries (2013-2018)
Table Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Countries (2013-2018)
Table Europe Onychomycosis (Tinea Unguium) Drug Revenue by Countries (2013-2018)
Figure Europe Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries in 2016
Figure Europe Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries in 2017
Figure Germany Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
Figure UK Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
Figure France Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
Figure Russia Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
Figure Italy Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
Table Europe Onychomycosis (Tinea Unguium) Drug Sales by Manufacturer (2016-2017)
Figure Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2016
Figure Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2017
Table Europe Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturer (2016-2017)
Figure Europe Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2016
Figure Europe Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2017
Table Europe Onychomycosis (Tinea Unguium) Drug Sales by Type (2013-2018)
Table Europe Onychomycosis (Tinea Unguium) Drug Sales Share by Type (2013-2018)
Table Europe Onychomycosis (Tinea Unguium) Drug Revenue by Type (2013-2018)
Table Europe Onychomycosis (Tinea Unguium) Drug Revenue Share by Type (2013-2018)
Table Europe Onychomycosis (Tinea Unguium) Drug Sales by Application (2013-2018)
Table Europe Onychomycosis (Tinea Unguium) Drug Sales Share by Application (2013-2018)
Table Europe Onychomycosis (Tinea Unguium) Drug Revenue by Application (2013-2018)
Table Europe Onychomycosis (Tinea Unguium) Drug Revenue Share by Application (2013-2018)
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales by Countries (2013-2018)
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Market Share by Countries 2017
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Countries (2013-2018)
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries 2017
Figure China Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
Figure Japan Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
Figure Korea Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
Figure India Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
Figure Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales by Type (2013-2018)
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Share by Type (2013-2018)
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Type (2013-2018)
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue Share by Type (2013-2018)
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales by Application (2013-2018)
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales Share by Application (2013-2018)
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Application (2013-2018)
Table Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue Share by Application (2013-2018)
Figure South America Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Table South America Onychomycosis (Tinea Unguium) Drug Sales by Countries (2013-2018)
Table South America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Countries (2013-2018)
Figure South America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Countries in 2017
Table South America Onychomycosis (Tinea Unguium) Drug Revenue by Countries (2013-2018)
Table South America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries (2013-2018)
Figure South America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries in 2017
Figure Brazil Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
Figure Argentina Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
Figure Colombia Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
Table South America Onychomycosis (Tinea Unguium) Drug Sales by Manufacturer (2016-2017)
Figure South America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2016
Figure South America Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2017
Table South America Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturer (2016-2017)
Figure South America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2016
Figure South America Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2017
Table South America Onychomycosis (Tinea Unguium) Drug Sales by Type (2013-2018)
Table South America Onychomycosis (Tinea Unguium) Drug Sales Share by Type (2013-2018)
Table South America Onychomycosis (Tinea Unguium) Drug Revenue by Type (2013-2018)
Table South America Onychomycosis (Tinea Unguium) Drug Revenue Share by Type (2013-2018)
Table South America Onychomycosis (Tinea Unguium) Drug Sales by Application (2013-2018)
Table South America Onychomycosis (Tinea Unguium) Drug Sales Share by Application (2013-2018)
Table South America Onychomycosis (Tinea Unguium) Drug Revenue by Application (2013-2018)
Table South America Onychomycosis (Tinea Unguium) Drug Revenue Share by Application (2013-2018)
Figure Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales by Countries (2013-2018)
Table Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Countries in 2017
Table Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue by Countries (2013-2018)
Table Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries in 2013
Figure Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries in 2017
Figure Saudi Arabia Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
Figure UAE Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
Figure Egypt Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
Figure Nigeria Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
Figure South Africa Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
Table Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales by Type (2013-2018)
Table Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales Share by Type (2013-2018)
Table Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue by Type (2013-2018)
Table Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue Share by Type (2013-2018)
Table Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales by Application (2013-2018)
Table Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales Share by Application (2013-2018)
Table Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue by Application (2013-2018)
Table Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue Share by Application (2013-2018)
Table Global Onychomycosis (Tinea Unguium) Drug Sales by Type (2013-2018)
Table Global Onychomycosis (Tinea Unguium) Drug Sales Share by Type (2013-2018)
Table Global Onychomycosis (Tinea Unguium) Drug Revenue by Type (2013-2018)
Table Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Type (2013-2018)
Figure Global Oral Sales Growth (2013-2018)
Figure Global Oral Price (2013-2018)
Figure Global External Sales Growth (2013-2018)
Figure Global External Price (2013-2018)
Table Global Onychomycosis (Tinea Unguium) Drug Sales by Application (2013-2018)
Table Global Onychomycosis (Tinea Unguium) Drug Sales Share by Application (2013-2018)
Figure Global Age under 18 Sales Growth (2013-2018)
Figure Global Age 18-50 Sales Growth (2013-2018)
Figure Global Age above 50 Sales Growth (2013-2018)
Figure Global Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Growth Rate (2018-2023)
Table Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Regions (2018-2023)
Table Global Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Regions (2018-2023)
Figure North America Sales Onychomycosis (Tinea Unguium) Drug Market Forecast (2018-2023)
Figure Europe Sales Onychomycosis (Tinea Unguium) Drug Market Forecast (2018-2023)
Figure Asia-Pacific Sales Onychomycosis (Tinea Unguium) Drug Market Forecast (2018-2023)
Figure South America Sales Onychomycosis (Tinea Unguium) Drug Market Forecast (2018-2023)
Figure Middle East and Africa Sales Onychomycosis (Tinea Unguium) Drug Market Forecast (2018-2023)
Table Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Type (2018-2023)
Table Global Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Type (2018-2023)
Table Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Application (2018-2023)
Table Global Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List